Takuhiro Yamaguchi

5PUBLICATIONS
33CO-AUTHORS
Environmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)HaematologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2026
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.

|Jun 10, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.

|Mar 25, 2021
An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study.

Takuro Mizukami, Tempei Miyaji, Yukiya Narita

|Oct 09, 2018
Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.

Takuhiro Yamaguchi, Yukio Kitajima, Yasuhiro Miyauchi

|Jun 29, 2017
Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).

Shunsuke Ohnishi, Hidemichi Watari, Maki Kanno

Pageof 1

Frequent Collaborators

2 joint publications

Yasuyuki Kojima

2 joint publications

Toshinari Yamashita

2 joint publications

Yasuaki Sagara

2 joint publications

Shigehira Saji